ERS 2026: obesity, an independent obstruction to biologic-treated asthma – Pharmaceutical Technology
For the purpose of this single-centre observational study, 82 patients who were prospectively treated with biologics were included.
With a free Pharmaceutical Technology profile, you can:
Powered by
Powered by
The leading site for news and procurement in the pharmaceutical industry
Powered by
© GlobalData Plc 2026
source
This article was autogenerated from a news feed from CDO TIMES selected high quality news and research sources. There was no editorial review conducted beyond that by CDO TIMES staff. Need help with any of the topics in our articles? Schedule your free CDO TIMES Tech Navigator call today to stay ahead of the curve and gain insider advantages to propel your business!
With a free Pharmaceutical Technology profile, you can:
Powered by
Powered by
The leading site for news and procurement in the pharmaceutical industry
Powered by
© GlobalData Plc 2026
source
This article was autogenerated from a news feed from CDO TIMES selected high quality news and research sources. There was no editorial review conducted beyond that by CDO TIMES staff. Need help with any of the topics in our articles? Schedule your free CDO TIMES Tech Navigator call today to stay ahead of the curve and gain insider advantages to propel your business!
